ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PJC Piper Jaffray Companies

79.62
0.00 (0.00%)
12 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Piper Jaffray Companies NYSE:PJC NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 79.62 0 01:00:00

Piper Jaffray Announces Addition to Hong Kong Investment Banking Group

30/06/2014 4:29am

Business Wire


Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Piper Jaffray Companies Charts.

Piper Jaffray Companies (NYSE: PJC), a leading investment bank and asset management firm, today announced that Andy Clayton has joined the firm as a principal in its investment banking group. He will be based in the firm’s Hong Kong office.

Clayton brings substantial cross-border M&A, equity and debt advisory experience to the firm. He was previously a senior vice president with Jefferies’ Hong Kong investment banking team, and prior to that, served as an investment banking director in UBS’ Hong Kong office. Clayton holds a bachelor’s degree from Williams College and a Master of Business Administration degree from the University of Chicago Booth School of Business.

“Piper Jaffray identified Andy as a proven leader to help strengthen our Asia investment banking efforts. His track record, global perspective and longstanding relationships will contribute meaningfully to our global healthcare franchise,” commented Scott LaRue, global co-head of investment banking and capital markets.

“We are excited to have someone of Andy’s caliber join our Asia team,” said JP Peltier, head of Piper Jaffray healthcare investment banking. “His healthcare experience, fluency in Mandarin Chinese and regional knowledge will greatly complement our strengths in Asia.”

Piper Jaffray has a global healthcare investment banking and capital markets team of more than 50 professionals. Since 2007, the team has represented clients in 325 transactions with an aggregate value of $55 billion. Year-to-date, the Piper Jaffray healthcare investment banking group has advised on 17 M&A transactions and 32 financings for an aggregate value of $9.95 billion.

In addition, the firm’s 10 healthcare senior research analysts cover a broad spectrum of sectors, including biotechnology, medical technology, specialty pharmaceuticals, drug discovery, medical diagnostics, life science tools and healthcare services, including information technology and alternate site providers.

About Piper Jaffray

Piper Jaffray Companies (NYSE: PJC) is an investment bank and asset management firm headquartered in Minneapolis with offices across the U.S. and in London, Hong Kong* and Zurich. Securities brokerage and investment banking services are offered in the United States through Piper Jaffray & Co., member NYSE and SIPC, and in Europe through Piper Jaffray Ltd., authorized and regulated by the Financial Conduct Authority. Asset management products and services are offered through three separate investment advisory affiliates registered with the U.S. Securities and Exchange Commission: Advisory Research Inc., Piper Jaffray Investment Management LLC and PJC Capital Partners LLC.

* Pending authorization and registration by the SFC

Follow Piper Jaffray: LinkedIn | Facebook

Since 1895. © 2014 Piper Jaffray Companies, 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402

Piper Jaffray CompaniesPamela Steensland, 612-303-8185pamela.k.steensland@pjc.com

1 Year Piper Jaffray Companies Chart

1 Year Piper Jaffray Companies Chart

1 Month Piper Jaffray Companies Chart

1 Month Piper Jaffray Companies Chart

Your Recent History

Delayed Upgrade Clock